247 related articles for article (PubMed ID: 31718891)
1. Diversity of complexes based on p-nitrobenzoylhydrazide, benzoylformic acid and diorganotin halides or oxides self-assemble: Cytotoxicity, the induction of apoptosis in cancer cells and DNA-binding properties.
Jiang W; Fan S; Zhou Q; Zhang F; Kuang D; Tan Y
Bioorg Chem; 2020 Jan; 94():103402. PubMed ID: 31718891
[TBL] [Abstract][Full Text] [Related]
2. Diorganotin (IV) complexes with 4-nitro-N-phthaloyl-glycine: Synthesis, characterization, antitumor activity and DNA-binding studies.
Yan C; Zhang J; Liang T; Li Q
Biomed Pharmacother; 2015 Apr; 71():119-27. PubMed ID: 25960226
[TBL] [Abstract][Full Text] [Related]
3. Self-assembly synthesis of diorganotin complexes based on arylformylhydrazone possessing ONO donor set: anticancer activity and mechanism.
Jiang W; Zhang Z; Ni P; Tan Y
Metallomics; 2022 May; 14(5):. PubMed ID: 35556135
[TBL] [Abstract][Full Text] [Related]
4. Aroylhydrazone Diorganotin Complexes Causes DNA Damage and Apoptotic Cell Death: From Chemical Synthesis to Biochemical Effects.
Jiang W; Tan Y; Peng Y
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948323
[TBL] [Abstract][Full Text] [Related]
5. Diorganotin(IV) complexes based on tridentate ONO ligands as potential anticancer agents.
Jiang W; Qin Q; Xiao X; Tan Y
J Inorg Biochem; 2022 Jul; 232():111808. PubMed ID: 35421767
[TBL] [Abstract][Full Text] [Related]
6. Novel di-n-butyltin(IV) derivatives: Synthesis, high levels of cytotoxicity in tumor cells and the induction of apoptosis in KB cancer cells.
Shang X; Ding N; Xiang G
Eur J Med Chem; 2012 Feb; 48():305-12. PubMed ID: 22226547
[TBL] [Abstract][Full Text] [Related]
7. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
8. Newly designed organotin(IV) carboxylates with peptide linkage: Synthesis, structural elucidation, physicochemical characterizations and pharmacological investigations.
Sirajuddin M; McKee V; Tariq M; Ali S
Eur J Med Chem; 2018 Jan; 143():1903-1918. PubMed ID: 29133050
[TBL] [Abstract][Full Text] [Related]
9. Dibutyltin(IV) Complexes Derived from L-DOPA: Synthesis, Molecular Docking, Cytotoxic and Antifungal Activity.
Rocha-Del Castillo E; Gómez-García O; Andrade-Pavón D; Villa-Tanaca L; Ramírez-Apan T; Nieto-Camacho A; Gómez E
Chem Pharm Bull (Tokyo); 2018; 66(12):1104-1113. PubMed ID: 30504627
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, structural characterization, and anticancer activity of a monobenzyltin compound against MCF-7 breast cancer cells.
Fani S; Kamalidehghan B; Lo KM; Hashim NM; Chow KM; Ahmadipour F
Drug Des Devel Ther; 2015; 9():6191-201. PubMed ID: 26648695
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, structural characterization and biological studies of the triphenyltin(IV) complex with 2-thiobarbituric acid.
Balas VI; Verginadis II; Geromichalos GD; Kourkoumelis N; Male L; Hursthouse MB; Repana KH; Yiannaki E; Charalabopoulos K; Bakas T; Hadjikakou SK
Eur J Med Chem; 2011 Jul; 46(7):2835-44. PubMed ID: 21521629
[TBL] [Abstract][Full Text] [Related]
12. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
13. Spectroscopic characterizations, structural peculiarities, molecular docking study and evaluation of biological potential of newly designed organotin(IV) carboxylates.
Sirajuddin M; Ali S; McKee V; Akhtar N; Andleeb S; Wadood A
J Photochem Photobiol B; 2019 Aug; 197():111516. PubMed ID: 31170508
[TBL] [Abstract][Full Text] [Related]
14. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
15. New bio-sensitive and biologically active single crystal of pyrimidine scaffold ligand and its gold and platinum complexes: DFT, antimicrobial, antioxidant, DNA interaction, molecular docking with DNA/BSA and anticancer studies.
Sankarganesh M; Dhaveethu Raja J; Sakthikumar K; Solomon RV; Rajesh J; Athimoolam S; Vijayakumar V
Bioorg Chem; 2018 Dec; 81():144-156. PubMed ID: 30121002
[TBL] [Abstract][Full Text] [Related]
16. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization and in vitro biological evaluation of novel organotin(IV) compounds with derivatives of 2-(5-arylidene-2,4-dioxothiazolidin-3-yl)propanoic acid.
Pantelić NĐ; Zmejkovski BB; Božić B; Dojčinović B; Banjac NR; Wessjohann LA; Kaluđerović GN
J Inorg Biochem; 2020 Oct; 211():111207. PubMed ID: 32801055
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
19. Potentially bioactive organotin(IV) compounds: synthesis, characterization, in vitro bioactivities and interaction with SS-DNA.
Sirajuddin M; Ali S; McKee V; Sohail M; Pasha H
Eur J Med Chem; 2014 Sep; 84():343-63. PubMed ID: 25036793
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of new Organotin(IV) anticancer agents and their cytotoxicity profile on HL-60, MCF-7 and HeLa human cancer cell lines.
Ullah H; Previtali V; Mihigo HB; Twamley B; Rauf MK; Javed F; Waseem A; Baker RJ; Rozas I
Eur J Med Chem; 2019 Nov; 181():111544. PubMed ID: 31374420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
